6C4U image
Entry Detail
PDB ID:
6C4U
Title:
Engineered FHA with Myc-pTBD peptide
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2018-01-12
Release Date:
2018-05-30
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Forkhead-associated 1
Chain IDs:A (auth: B), B (auth: C), C (auth: D), D (auth: E), E (auth: A), F
Chain Length:134
Number of Molecules:6
Biological Source:Saccharomyces cerevisiae
Polymer Type:polypeptide(L)
Description:Myc-pTBD peptide
Chain IDs:G, H (auth: I), I (auth: H), J, K (auth: L), L (auth: K)
Chain Length:9
Number of Molecules:6
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Generating a recombinant phosphothreonine-binding domain for a phosphopeptide of the human transcription factor, c-Myc.
N Biotechnol 45 36 44 (2018)
PMID: 29763736 DOI: 10.1016/j.nbt.2018.05.001

Abstact

Transcription factor c-Myc is an oncoprotein that is regulated at the post-translational level through phosphorylation of two conserved residues, Serine 62 (Ser62) and Threonine 58 (Thr58). A highly specific tool capable of recognizing Myc via pThr58 is needed to monitor activation and localization. Through phage display, we have isolated 10 engineered Forkhead-associated (FHA) domains that selectively bind to a phosphothreonine (pThr)-containing peptide (53-FELLPpTPPLSPS-64) segment of human c-Myc. One domain variant was observed to bind to the Myc-pThr58 peptide with a KD value of 800 nM and had >1000-fold discrimination between the phosphorylated and non-phosphorylated peptide. The crystal structure of the engineered FHA Myc-pThr-binding domain (Myc-pTBD) was solved in complex with its cognate ligand. The Myc-pTBD was observed to be structurally similar to the yeast Rad9 FHA1 domain, except that its β4-β5 and β10-β11 loops form a hydrophobic pocket to facilitate the interaction between the domain and the peptide ligand. The Myc-pTBD's specificity for its cognate ligand was demonstrated to be on a par with 3 commercial polyclonal antibodies, suggesting that this recombinant reagent is a viable alternative to antibodies for monitoring Myc regulation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures